AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential Disease-Modifying Effect of NeuroRestore ACD856

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both...

Related Keywords

Sweden ,Stockholm ,Swedish ,Nather Madjid ,Johan Sandin ,Gunnar Nordvall ,Alzecure Pharma ,Cristina Parrado Fern ,Pontus Forsell ,Sanja Juric ,Maria Backlund , ,Alzecure Presents New Data ,Potential Disease Modifying Effect ,Nasdaq First North Premier Growth Market ,Nerve Growth Factor ,Brain Derived Neurotrophic Factor ,Current Events ,News ,Press Release ,Echnological News ,Omputer News ,Cientific News ,Usiness News ,Health News ,Nvironmental News ,Sports News ,Eisure Activities News ,Transportation News ,Ravelling News ,Ourism News ,Ciences ,Business ,Health ,Environment ,Sports ,Leisure Activities ,Ransportation ,Travelling ,Holidays ,Tourism ,